And no CE as promised for months ago for these devices yet and no news re the delay! It has cost $ millions and we get no explanation as to how things are actually going. Tip 'em out!
Ann: AstraZeneca to use new ResApp software in clinical study, page-121
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #